Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lotiglipron

A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Dru

Pfizer · Phase 1 · Terminated · Enrollment 32

NCT05671653

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cohort 1: PF-07081532n/rn/rn/rn/r
Cohort 2: Semaglutiden/rn/rn/rn/r

Not shown

  • Cohort 1: PF-07081532: endpoint not reported
  • Cohort 2: Semaglutide: endpoint not reported